sikalische Medizin Akademischer Bericht 2004 - Rheumaklinik ...

Lecture “Molecular and cellular basis of rheumatoid joint destruction - Novel therapeutic targets designed by gene transfer”, AMGEN, Los
Angeles CA, March 17, 2004
Lecture, “Molecular and cellular basis of rheumatoid joint destruction and gene transfer to detect novel targets for the treatment of RA, CIS
Spring School, Santa Fe, NM, March 20, 2004
Lecture, “New targets in the treatment of inflammation”, 3rd Annual Meeting of the Institute of Arthritis Pain, London, UK, March 27, 2004
Lecture, “Molecular and cellular basis of rheumatoid joint destruction - Novel therapeutic targets designed by gene transfer”, 4th Integrated
Course – Advances in Molecular Medicine, University of Poznan, Poland, March 30, 2004
Lecture, “Cytokine-dependent and cytokine-independent mechanisms of synovitis predicting therapeutic outcomes”, XII Congresso Portuges
de Reumatologia, Estoril, Portugal, April 1, 2004
Lecture, “Molecular and cellular pathways of joint destruction - Lessons from gene transfer”, XII Congresso Portuges de Reumatologia,
Estoril, Portugal, April 2, 2004
Lecture,” Synovial fibroblast mediated joint destruction”, 13th International Rheumatology Symposium, Okayama, Japan, April 15, 2004
Lecture, “Cytokine-independent pathways contribute significantly to the destruction of joints in rheumatoid arthritis”, 48th Annual Scientific
Meeting of Japan College of Rheumatology, Okayama April 16, 2004
Lecture, “Cytokine-dependent and cytokine-independent pathways of synovitis predicting therapeutic outcomes”, Abbott, Chicago, IL, USA,
April 19, 2004
Lecture, “Cytokine-dependent and cytokine-independent pathways of synovitis predicting therapeutic outcomes”, Pfizer, New York, NY,
USA, April 21, 2004
Lecture, “TOLL-like receptors in rheumatoid arthritis”, Advances in Targeted Therapies, Venice, Italy, May 1, 2004
Lecture, “Potential triggers in the activation of synovial cells in rheumatoid arthritis”, Annual Congress, European League against Rheuma-
tism (EULAR), Berlin, Germany, June 10, 2004
Lecture, “Musculoskeletal disorders – Is the cure in our genes?”, Fifth International Scientific Conference on Prevention of Work Related
Mulsculoskeletal Disorders, PREMUS 2004, Zurich, July 12, 2004
Lecture, “Molecular and cellular basis of rheumatoid joint destruction and Gene transfer to detect novel targets for the treatment of RA”,
EFIS, Belgrade, Serbia/Montenegro, Aug 30, 2004
Lecture, “Molecular and cellular players mediating joint destruction – Novel therapeutic targets designed by gene transfer”, APLAR 2004,
Jeju Island, Korea, September 11, 2004
Lecture, “Molecular and cellular basis of rheumatoid joint destruction - Novel therapeutic targets designed by gene transfer”, Biogen, Bos-
ton, MA, USA, September 17, 2004
Lecture, “Gentransfer zur Identifikation neuer therapeutischer Strategien zur Behandlung von Rheumapatienten”, University of Tübingen,
Germany, October 2, 2004
Lecture, “Novel pathways of synovial activation in rheumatoid arthritis detected by gene transfer“, 1st International Conference on Basic and
Clinical Immunogenomics, Budapest, Hungary, October 6, 2004
Lecture, “Molecular and cellular basis of cartilage destruction in rheumatoid arthritis – Novel insights from gene transfer“, 28. Ludwig-
Heilmeyer-Symposium, Köln, Germany, October 23, 2004
Lecture, “Gene transfer to design novel treatments for rheumatoid arthritis”, 4th International Congress on Autoimmunity, Budapest, No-
vember 4, 2004
Lecture, „Molekulare und zelluläre Basis der Gelenkdestruktion bei Rheumatoid Arthritis“, 12. Sächischer Internistenkongress, Chemnitz,
Germany, November 12, 2004
Lecture, ”Cytokine-dependent and cytokine-independent pathways in RA - Novel predictors of outcome in clinical trials”, Wyeth, Prague Nov
29 2004
12